Medical Economics September 11, 2023
Jeffrey Bendix

Legislation also provides more funding for community health centers and diabetes research

A bipartisan bill designed to increase health care price transparency and lower costs for prescription drugs and health care services was introduced September 8 by the chairs of three House of Representatives committees with jurisdiction over health care.

Dubbed the “Lower Costs, More Transparency Act” the bill would, among other provisions, require health insurers and pharmacy benefit managers (PBMs) to disclose negotiated drug rebates and discounts, reduce out-of-pocket costs for seniors who receive medication at a hospital-owned outpatient facility or doctor’s office, and extend funding for research into diabetes treatments.

“Our bipartisan legislation…will lower costs by giving patients the health care price information they need to make the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Healthcare System, Insurance, Patient / Consumer, Pharma, Pharma / Biotech, Pricing / Spending, Provider, Regulations
If enhanced ACA subsidies expire, 4M could become uninsured: report
MTT #89: Trump’s second term, weight-loss drugs & the rise of ‘walking pneumonia’
Looking to history to prepare for America’s uncertain future
Trump transition closes in on picks for top health posts
What will happen in healthcare following the election? Hear from our experts.

Share This Article